SCHEMBL21155985

SCHEMBL21155985

N#Cc1ccc(-c2nc(-n3c4cccnc4c4c5ccccc5c5c6ccccc6sc5c43)nc3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.33
ATM Q13315 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 3/20 0.31
PDE4A P27815 2/20 0.31
EGLN1 Q9GZT9 1/20 0.31
ALOX5 P09917 1/20 0.31
ADORA2A P29274 2/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPK1 P28482 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TDO2 P48775 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988657 0.91 ALDH1A1 (0.38) ATMMEN1KMT2AALDH1A1HPGD
SCHEMBL19988518 0.91 ALDH1A1 (0.39) ATMMEN1KMT2AALDH1A1HPGD
SCHEMBL19988439 0.91 ADORA2A (0.43) PDE10AMEN1KMT2AALDH1A1HPGD
SCHEMBL19988636 0.90 ADORA2A (0.30) ADORA2A
SCHEMBL21155413 0.87 KDM4E (0.32) ATMALDH1A1HPGDKDM4EMAPT
SCHEMBL19988447 0.86 ALDH1A1 (0.39) ATMMEN1KMT2AALDH1A1HPGD
SCHEMBL19988463 0.86 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EMAPTNPSR1
SCHEMBL19988514 0.86 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EMAPTNPSR1
SCHEMBL19988627 0.85 TOP1 (0.34) ATMMEN1KMT2AALDH1A1HPGD
SCHEMBL19988445 0.85 ALDH1A1 (0.35) ALDH1A1HPGDKDM4EMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 PDE10A 3202/4885ATM 3761/4885MEN1 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.